Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
CARD8 rs2043211 polymorphism is associated with gout in a Chinese male population
Ying Chen1, Xianfeng Ren, Changgui Li
1Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, China.
Insights
Genetic factors influence gout development. This study found a significant association between the CARD8 rs2043211 polymorphism and gout susceptibility in Chinese Han males, impacting triglyceride levels and blood pressure.
Area of Science:
- Genetics
- Rheumatology
- Molecular Biology
Background:
- Gout is a complex disease with suspected genetic underpinnings.
- Previous research indicates a role for genetic factors in gout pathogenesis.
- The CARD8 rs2043211 polymorphism is a candidate gene for investigation.
Purpose of the Study:
- To investigate the genetic association between the CARD8 rs2043211 polymorphism and gout.
- To explore genotype-phenotype correlations in relation to gout.
Main Methods:
- A case-control study involving 396 male gout patients and 403 healthy controls.
- Genotyping performed using TaqMan SNP Genotyping Assays.
- Association analysis conducted using the chi-squared test and genotype-phenotype analysis.
Main Results:
- The CARD8 rs2043211 polymorphism genotype distribution was in Hardy-Weinberg equilibrium in controls (P = 0.27).
- A significant difference in genotype distribution was observed between gout cases and controls (P = 0.017).
- The CARD8 rs2043211 polymorphism was significantly associated with gout under a recessive model (OR = 0.65, 95%CI 0.47-0.88, P = 0.006).
- Carriers of the TT genotype exhibited higher triglyceride levels, elevated systolic blood pressure, and an increased risk of renal calculus compared to AA genotype carriers.
Conclusions:
- The CARD8 rs2043211 polymorphism is significantly associated with gout susceptibility in Chinese Han males.
- This polymorphism may influence metabolic and clinical features associated with gout.
Abstract:
BACKGROUND &AIM: Previous studies have suggested genetic factors are involved in the development of gout. We performed a case-control study to investigate the genetic association between CARD8 rs2043211 polymorphism and gout.
Methods:
A total of 396 male patients with gout and 403 age- and sex- matched healthy controls were included in this study. Genotyping was performed using TaqMan SNP Genotyping Assays. An association analysis was carried out using the χ² test. The genotype-phenotype analysis was also conducted.
Results:
The genotype distribution of CARD8 rs2043211 polymorphism confirmed to HWE in the controls (P = 0.27). There was an obvious difference in the genotype distribution of CARD8 rs2043211 polymorphism between cases and controls (P = 0.017). In addition, there was an obvious association between CARD8 rs2043211 polymorphism and gout under the recessive comparison model (AA vs.
Tt/Ta:
OR = 0.65, 95%CI 0.47-0.88, P = 0.006). Patients carrying genotype TT of CARD8 rs2043211 polymorphism had higher triglycerides levels compared to those carrying the AA genotype (2.77±2.08 mmol/L vs. 2.07±1.15 mmol/L, P = 0.01). Patients with the TT genotype also had significantly higher systolic blood pressure compared with those with the AA genotype (142.11±21.10 mmHg vs. 135.38±14.66 mmHg, P = 0.03). Patients carrying TT genotype also had an increased risk of renal calculus compared with those carrying the AA genotype.
Conclusion:
CARD8 rs2043211 polymorphism is significantly associated with susceptibility to gout in Chinese Han males.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Principles of Pharmacogenetics: Types of Genetic Variants
